By Heather VanBlarcom General Counsel & Senior Regulatory Specialist for Dietary Supplements At the NBJ Summit last week in Dana Point, CA, David C. Vladeck, the Director of the Federal […] Read More >>
By William Morkel, Director of Quality & Compliance February 7, 2012 Sometime in early 2010 the Natural Health Products Directorate (NHPD) decided to halt reviews of all product licence applications […] Read More >> May 27, 2011 Rejected health claims may remain usable for extended periods after confirmation from the European Commission that rejected article 13.5 claims can gain an extended life if […] Read More >> May 30, 2011 EFSA gives positive opinion on blood cholesterols claim The European Food Safety Authority (EFSA) has concluded that a cause and effect relationship has been established between […] Read More >> May 16, 2011 Omega-3 scientists oppose EFSA ALA claim An omega-3 researcher has written to the European Commission demanding a recent European Food Safety Authority (EFSA)-approved claim for omega-3 […] Read More >> Denmark clamps down on glucosamine products By Shane Starling, 02-May-2011 The Danish Medicines Agency (DMA) has issued a warning against illegal glucosamine medicines being sold on a Danish website […] Read More >> Health claims beyond EFSA and the Commission: enter the European Parliament 17 April 2011 **Comment piece by Nathalie Wood, Food Regulation and Policy Manager, EAS Last month’s near-death of […] Read More >> FDA Warns Rishi Teas for Website Claims April 26, 2011 MINNEAPOLIS, Minn.—FDA warned Diaspora Tea & Herb Co. LLC that some of its Rishi Teas were promoted for conditions […] Read More >> EFSA rolls out re-organisation programme to meet demands, optimise resources May 2, 2011 The European Food Safety Authority (EFSA) has begun rolling out its re-organisation programme, making best use […] Read More >> April 7, 2011 Adverse drug reactions (ADRs) reported to the US Food and Drug Administration (FDA) have increased dramatically over the past decade, according to new research from the […] Read More >> EFSA’s NDA Panel[1] has published the outcome of the evaluations of a fourth series of ‘general function’ health claims[2] proposed for use on food products. The 442 claims assessed […] Read More >> WASHINGTON—FDA issued a consumer warning regarding Soladek, a vitamin product marketed by Indo Pharma SA, based in the Dominican Republic, as the product may contain dangerously high levels of […] Read More >>
  February 22-23, 2011 in Toronto. Dicentra has agreed to be a Gold Sponsor to this important and informative event and our own Candice Cryne, Scientific Regulatory Associate will be […] Read More >>